MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 48 filers reported holding MYOVANT SCIENCES LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $22,410,499 | +51.8% | 831,250 | +1.1% | 0.00% | – |
Q3 2022 | $14,760,000 | +38.2% | 821,841 | -4.3% | 0.00% | – |
Q2 2022 | $10,679,000 | +2.4% | 859,155 | +9.7% | 0.00% | – |
Q1 2022 | $10,431,000 | -15.0% | 783,037 | -0.6% | 0.00% | – |
Q4 2021 | $12,272,000 | -31.7% | 788,160 | -1.5% | 0.00% | – |
Q3 2021 | $17,965,000 | +1.9% | 800,545 | +3.4% | 0.00% | – |
Q2 2021 | $17,631,000 | +12.9% | 774,317 | +2.1% | 0.00% | – |
Q1 2021 | $15,612,000 | +281.1% | 758,579 | +411.5% | 0.00% | – |
Q4 2020 | $4,097,000 | +34.7% | 148,318 | -31.5% | 0.00% | – |
Q3 2020 | $3,041,000 | +3.6% | 216,463 | +52.1% | 0.00% | – |
Q2 2020 | $2,934,000 | +187.6% | 142,308 | +5.3% | 0.00% | – |
Q1 2020 | $1,020,000 | -49.6% | 135,197 | +3.7% | 0.00% | – |
Q4 2019 | $2,022,000 | +219.9% | 130,368 | +7.2% | 0.00% | – |
Q3 2019 | $632,000 | -43.5% | 121,572 | -1.8% | 0.00% | – |
Q2 2019 | $1,119,000 | +217.9% | 123,756 | +313.1% | 0.00% | – |
Q1 2017 | $352,000 | -0.6% | 29,958 | +5.0% | 0.00% | – |
Q4 2016 | $354,000 | – | 28,518 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 3,474,645 | $26,234,000 | 74.74% |
Opaleye Management Inc. | 656,000 | $4,953,000 | 1.31% |
Ghost Tree Capital, LLC | 585,000 | $4,417,000 | 1.17% |
Cormorant Asset Management, LP | 2,600,000 | $19,630,000 | 0.91% |
Bellevue Group AG | 4,815,109 | $36,354,000 | 0.70% |
Values First Advisors, Inc. | 32,818 | $247,777 | 0.30% |
Amia Capital LLP | 41,970 | $317,000 | 0.28% |
Ikarian Capital, LLC | 450,000 | $3,398,000 | 0.26% |
Eventide Asset Management | 800,000 | $6,040,000 | 0.20% |
Rock Springs Capital Management LP | 500,000 | $3,775,000 | 0.16% |